CEREBROSPINAL-FLUID IMMUNOREACTIVE CORTICOTROPIN-RELEASING HORMONE AND ADRENOCORTICOTROPIN SECRETION IN CUSHINGS-DISEASE AND MAJOR DEPRESSION - POTENTIAL CLINICAL IMPLICATIONS

被引:136
|
作者
KLING, MA
ROY, A
DORAN, AR
CALABRESE, JR
RUBINOW, DR
WHITFIELD, HJ
MAY, C
POST, RM
CHROUSOS, GP
GOLD, PW
机构
[1] NIMH, CLIN NEUROSCI BRANCH, BETHESDA, MD 20892 USA
[2] NIMH, BIOL PSYCHIAT BRANCH, BETHESDA, MD 20892 USA
[3] NIA, NEUROSCI LAB, BETHESDA, MD 20892 USA
[4] NICHHD, DEV ENDOCRINOL BRANCH, BETHESDA, MD 20892 USA
来源
关键词
D O I
10.1210/jcem-72-2-260
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To explore whether possible differences in central nervous system neuromodulators contribute to the differential presentation of affective symptomatology in Cushing's disease and major depression, we examined the levels of immunoreactive CRH and ACTH in the cerebrospinal fluid (CSF) of 11 patients with Cushing's disease, a patient with ectopic ACTH secretion, 34 patients with major depression, and 60 healthy subjects. We elected to measure these peptides not only because both are classically involved in pituitary-adrenal regulation, but also because their primarily arousal-producing and anorexigenic behavioral effects in experimental animals suggest that they may play a role in the symptom complex of depressive syndromes. We also explored whether the CSF levels of these peptides were more helpful in determining the often difficult differential diagnosis between major depression and Cushing's disease than the plasma ACTH response to ovine CRH, a currently used but somewhat insensitive laboratory means of distinguishing these disorders. CSF levels of immunoreactive CRH and ACTH were significantly lower in Cushing's disease patients [21.9 +/- 2.7 and 15.4 +/- 1.8 pg/mL, (mean +/- SEM), respectively] compared to patients with major depression [38.4 +/- 2.3 pg/mL (P < 0.01) and 24.5 +/- 1.6 pg/mL (P < 0.01), respectively] and controls [38.4 +/- 1.6 pg/mL (P < 0.001) and 26.3 +/- 1.1 pg/mL (P < 0.001), respectively]. The coexistence of high plasma ACTH and low CSF ACTH in Cushing's disease yielded a CSF/plasma ACTH ratio consistently less than that in depressed patients, with only 2 of 31 subjects comprising both groups showing values that overlapped. In contrast, 9 of the combined patients showed ACTH responses to ovine CRH that overlapped. These data suggest that differences in centrally directed CRH secretion may account for the differential presentation of the dysphoric syndromes seen in major depression and Cushing's disease. Hence, the classic form of major depression (melancholia), is often associated with evidence of pathological hyperarousal, such as intense anxiety, sleeplessness, and anorexia, while that of Cushing's disease is associated with evidence of pathological hypoarousal, including hyperphagia, fatigue, and inertia. Moreover, measurement of the CSF/plasma ACTH ratio may serve as a clinically useful adjunct to the ovine CRH stimulation test and other laboratory measures in determining the differential diagnosis between major depression and Cushing's disease.
引用
收藏
页码:260 / 271
页数:12
相关论文
共 50 条
  • [31] THE OVINE CORTICOTROPIN-RELEASING HORMONE (CRH) STIMULATION TEST IS SUPERIOR TO THE HUMAN CRH STIMULATION TEST FOR THE DIAGNOSIS OF CUSHINGS-DISEASE
    NIEMAN, LK
    CUTLER, GB
    OLDFIELD, EH
    LORIAUX, DL
    CHROUSOS, GP
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 69 (01): : 165 - 169
  • [32] SELECTIVE BILATERAL BLOOD-SAMPLING FROM THE INFERIOR PETROSAL SINUS IN CUSHINGS-DISEASE - EFFECTS OF CORTICOTROPIN-RELEASING FACTOR AND THYROTROPIN-RELEASING-HORMONE ON PITUITARY SECRETION
    STRACK, TR
    SCHILD, HH
    BOHL, J
    BEYER, J
    SCHREZEMEIR, J
    KAHALY, G
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 1993, 16 (05) : 287 - 292
  • [33] THE ROLE OF CORTICOTROPIN-RELEASING HORMONE IN THE PATHOGENESIS OF CUSHINGS-DISEASE, ANOREXIA-NERVOSA, ALCOHOLISM, AFFECTIVE-DISORDERS AND DEMENTIA
    HOLSBOER, F
    SPENGLER, D
    HEUSER, I
    PROGRESS IN BRAIN RESEARCH, 1992, 93 : 385 - 417
  • [34] THE USE OF THE CORTICOTROPIN-RELEASING HORMONE TEST TO MONITOR THE RECOVERY OF PATIENTS WITH CUSHINGS-DISEASE OR CUSHINGS-SYNDROME DUE TO AN ADRENAL ADENOMA AFTER ADENOMECTOMY
    HOTTA, MN
    SHIBASAKI, T
    SUDA, T
    LING, N
    SHIZUME, K
    ENDOCRINOLOGIA JAPONICA, 1985, 32 (01): : 113 - 125
  • [35] Cerebrospinal fluid levels of glutamate and corticotropin releasing hormone in major depression before and after treatment
    Garakani, Amir
    Martinez, Jose M.
    Yehuda, Rachel
    Gorman, Jack M.
    JOURNAL OF AFFECTIVE DISORDERS, 2013, 146 (02) : 262 - 265
  • [36] CEREBROSPINAL-FLUID CORTICOTROPIN-RELEASING HORMONE AND ACTH, AND PERIPHERALLY CIRCULATING CHOLINE-CONTAINING PHOSPHOLIPID IN SENILE DEMENTIA
    SUEMARU, S
    SUEMARU, K
    HASHIMOTO, K
    OGASA, T
    HIRASAWA, R
    MAKINO, S
    KAGEYAMA, J
    LIFE SCIENCES, 1993, 53 (09) : 697 - 706
  • [37] A DIURNAL RHYTHM IN CEREBROSPINAL-FLUID CORTICOTROPIN-RELEASING HORMONE DIFFERENT FROM THE RHYTHM OF PITUITARY-ADRENAL ACTIVITY
    KALIN, NH
    SHELTON, SE
    BARKSDALE, CM
    BROWNFIELD, MS
    BRAIN RESEARCH, 1987, 426 (02) : 385 - 391
  • [38] CORTICOTROPIN-RELEASING HORMONE STIMULATION TEST BEFORE AND AFTER TRANS-SPHENOIDAL SELECTIVE MICROADENOMECTOMY IN 30 PATIENTS WITH CUSHINGS-DISEASE
    SCHRELL, U
    FAHLBUSCH, R
    BUCHFELDER, M
    RIEDL, S
    STALLA, GK
    MULLER, OA
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 64 (06): : 1150 - 1159
  • [39] STIMULATION BY PEPTIDE HISTIDINE METHIONINE (PHM) OF ADRENOCORTICOTROPIN SECRETION IN PATIENTS WITH CUSHINGS-DISEASE - A COMPARISON WITH THE EFFECT OF VASOACTIVE-INTESTINAL-PEPTIDE (VIP) AND A STUDY ON THE EFFECT OF COMBINED ADMINISTRATION OF CORTICOTROPIN-RELEASING HORMONE WITH PHM OR VIP
    WATANOBE, H
    TAMURA, T
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (06): : 1372 - 1377
  • [40] MULTIPLE FEEDBACK REGULATORY LOOPS UPON RAT HYPOTHALAMIC CORTICOTROPIN-RELEASING HORMONE-SECRETION - POTENTIAL CLINICAL IMPLICATIONS
    CALOGERO, AE
    GALLUCCI, WT
    GOLD, PW
    CHROUSOS, GP
    JOURNAL OF CLINICAL INVESTIGATION, 1988, 82 (03): : 767 - 774